Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Itziar M. D. Posada"'
Autor:
Itziar M. D. Posada, Benoit Lectez, Farid A. Siddiqui, Christina Oetken-Lindholm, Mukund Sharma, Daniel Abankwa
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Abstract As a major growth factor transducer, Ras is an upstream activator of mTORC1, which further integrates nutrient and energy inputs. To ensure a contextual coupling of cell division via Ras/MAPK-signalling and growth via mTORC1-signalling, feed
Externí odkaz:
https://doaj.org/article/37bdb60d533147c484ba87879ea57fcb
Autor:
Itziar M D Posada, Marc Serulla, Yong Zhou, Christina Oetken-Lindholm, Daniel Abankwa, Benoît Lectez
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159677 (2016)
Ras-induced senescence mediated through ASPP2 represents a barrier to tumour formation. It is initiated by ASPP2's interaction with Ras at the plasma membrane, which stimulates the Raf/MEK/ERK signaling cascade. Ras to Raf signalling requires Ras to
Externí odkaz:
https://doaj.org/article/bb928b75dddf4e7e962a561201664ec9
Autor:
Christina Oetken-Lindholm, Mukund Sharma, Farid Ahmad Siddiqui, Daniel Abankwa, Itziar M. D. Posada, Benoit Lectez
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
Scientific Reports. London, United Kingdom: Nature Publishing Group (2017).
Scientific Reports
Scientific Reports. London, United Kingdom: Nature Publishing Group (2017).
Scientific Reports
As a major growth factor transducer, Ras is an upstream activator of mTORC1, which further integrates nutrient and energy inputs. To ensure a contextual coupling of cell division via Ras/MAPK-signalling and growth via mTORC1-signalling, feedback loop
Autor:
Ernest Lacey, Tero Aittokallio, Camilo Guzmán, Benoit Lectez, Arafath Kaja Najumudeen, Elina Siljamäki, Alok Jaiswal, Itziar M. D. Posada, Christina Oetken-Lindholm, Daniel Abankwa
Publikováno v:
Oncogene
Cancer stem cells (CSCs) are considered to be responsible for treatment relapse and have therefore become a major target in cancer research. Salinomycin is the most established CSC inhibitor. However, its primary mechanistic target is still unclear,
Autor:
Igor L. Barsukov, Hans-Juergen Kreienkamp, Guillaume Jcaquement, Johanna Ivaska, Itziar M. D. Posada, Ella-Maria Vesilahti, Petra Laasola, Mitro Miihkinen, Siiri I. Salomaa, Daniel Abankwa, Johanna Lilja
Publikováno v:
Molecular Cancer Research. 18:B29-B29
RAS proteins play a direct causal role in human cancers, with activating mutations in RAS occurring in ∼30% of tumors. Despite comprehensive efforts, efficient targeting of RAS has not yet reached the clinic. Here, we report SHANK3, a synaptic scaf
Autor:
Yong Zhou, Christina Oetken-Lindholm, Benoit Lectez, Itziar M. D. Posada, Tero Aittokallio, Daniel Abankwa, Laxman Yetukuri, Mukund Sharma
Publikováno v:
Oncotarget
Oncotarget, Vol. 8((No. 27)), 44550-44566. Albany, NY: Impact Journals (2017).
Oncotarget, Vol. 8((No. 27)), 44550-44566. Albany, NY: Impact Journals (2017).
Currently several combination treatments of mTor- and Ras-pathway inhibitors are being tested in cancer therapy. While multiple feedback loops render these central signaling pathways robust, they complicate drug targeting. Here, we describe a novel H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb5b7c4615404edc2ed4e1a9bf3c3a0c
http://hdl.handle.net/10138/214063
http://hdl.handle.net/10138/214063
Autor:
Yong Zhou, Christina Oetken-Lindholm, Daniel Abankwa, Benoit Lectez, Itziar M. D. Posada, Marc Serulla
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159677 (2016)
PLoS ONE
PLoS ONE
Ras-induced senescence mediated through ASPP2 represents a barrier to tumour formation. It is initiated by ASPP2’s interaction with Ras at the plasma membrane, which stimulates the Raf/MEK/ERK signaling cascade. Ras to Raf signalling requires Ras t
Autor:
Benoit Lectez, Mukund Sharma, Farid Ahmad Siddiqui, Daniel Abankwa, Tero Aittokallio, Laxman Yetukuri, Itziar M. D. Posada, Christina Oetken-Lindholm, Yong Zhou
Publikováno v:
ESMO Open. 3:A57
Introduction PI3K/mTORC1- and Ras/MAPK-signalling pathways are aberrantly regulated in most cancers. Specific resistances to drugs targeting these pathways can emerge during tumour evolution. Preexisting, innate resistance mechanisms, such as stemmin
Autor:
Yong Zhou, Adyary Fallarero, Pia Vuorela, Itziar M. D. Posada, Benoit Lectez, Arafath Kaja Najumudeen, Daniel Abankwa, John F. Hancock, Sebastian K.-J. Landor
Publikováno v:
Biochemistry. 54(49)
Ras isoforms H-, N-, and K-ras are each mutated in specific cancer types at varying frequencies and have different activities in cell fate control. On the plasma membrane, Ras proteins are laterally segregated into isoform-specific nanoscale signalin
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 1298
Rab proteins constitute the largest subfamily of Ras-like small GTPases. They are central to vesicular transport and organelle definition in eukaryotic cells. Unlike their Ras counterparts, they are not a hallmark of cancer. However, a number of dise